Scottish Medical Journal

Our medical research library holds 6 studies published in Scottish Medical Journal (1970–2014). Each entry links to the study's record on PubMed and, where there is one, to the publisher's page and a free full text. 4 have an abstract, the authors' own summary as PubMed records it: open "Abstract" to read it. For 1 study PubMed has no abstract for, we give the abstract printed in the article or, where there is none, a summary we wrote from it, each labeled as such.

About the journal

• Publisher: Sage
• Published: 1956 to the present, Scotland
• Language: English
• ISSN: 0036-9330 (print), 2045-6441 (electronic)
• Merged from: Edinburgh Medical Journal
• Merged from: Glasgow Medical Journal
• Its record in the NLM Catalog

2010s

• Well-differentiated papillary mesothelioma: peritoneal implants are not always metastases in the presence of cancer. G.W. Irwin, A. Ervine, J.A. Kennedy. 2014;59(1):e18-21. Case report PubMed · Publisher

  Abstract

  Introduction: Well-differentiated papillary mesothelioma is a rare condition that can cause diagnostic uncertainty. Its appearance resembles metastatic deposits and in the presence of a known primary can often be confused for such.

  Case Presentation: In this case, we present a patient who had WDPM in the presence of gastric cancer and emphasise the difficulties in making the diagnosis.

  Conclusion: We highlight the need for a high index of suspicion, biopsies at staging laparoscopy and undertake a review of the literature regarding this uncommon condition.

• Abnormal activated partial thromboplastin time and malignancy. M. Delicata, H. Hambley. 2011;56(3):181. Case report PubMed · Publisher

  Abstract

  Malignancy often results in clotting abnormalities. The aetiology of haemostasis problems in cancer is complex, and is still not completely understood. We describe a case of a patient with malignant mesothelioma, who was found to have elevated activated partial thromboplastin time, due to lupus anticoagulant. We suggest that patients with malignancy should have their coagulation checked prior to any invasive procedures.

1990s

• Clinical features and epidemiology of malignant pleural mesothelioma in west Glasgow 1987-1992. A.N. McLean, K.R. Patel. 1997;42(2):37-9. PubMed · Publisher

  Abstract

  Malignant pleural mesothelioma is almost exclusively caused by exposure to asbestos dust. Recent epidemiological studies have suggested that the national incidence of disease may continue to rise until 2020 and that asbestos exposure in the building trade may be replacing shipyard related exposure as the main source of disease. The objective of the study was to determine if the incidence of malignant pleural mesothelioma was rising in the west of Glasgow from 1987-1992 and whether there had been a change in clinical features compared to previous studies from the same population. Case notes identified from coded returns and the local cancer registry were retrospectively examined: 144 cases were identified. This is an increase in incidence of over 50% compared to the previous study but the yearly incidence did not rise over the period studied. The clinical features and survival times have not changed since previous studies: median survival remains 30 weeks. Only three patients were given definitive treatment reflecting the lack of effective therapy. We suggest that the incidence of mesothelioma in the population studied may already have peaked resulting from the decline in the local shipyard industry over 20 years ago. Non-shipyard sources of asbestos exposure may be less important in this area.

1980s

• Recurrent pneumothorax: an unusual presentation of malignant mesothelioma. S.I. Handa, A.G. Wilkinson. 1989;34(6):566. Case report PubMed · Publisher

  Abstract

  Malignant mesothelioma is an uncommon condition with about 250 new cases each year in the United Kingdom, most of which present with dyspnoea due to pleural effusion or chest pain. We report a case of malignant mesothelioma which presented as recurrent pneumothorax.

1970s

• Home interviews with relatives of deceased persons: a means of obtaining histories of exposure to a hazardous substance. A. Finlayson, J. McEwen, A. Mair. 1971;16(12):509-12. PubMed · Publisher

• Practical steps towards the prevention of bronchial carcinoma. R. Doll. 1970;15(12):433-47. PubMed · Publisher

  Summary

  In this lecture, the author reviewed the agents known to cause bronchial carcinoma and discussed practical steps to reduce the risk. The agents considered were chrome ore, nickel ore, mustard gas, arsenic, asbestos, coal tar, ionizing radiations and cigarette smoke. Three studies of heavily exposed asbestos workers, two in England and one in the United States, had found grossly increased lung cancer mortality, for example 27 observed against 2.3 expected deaths in insulation workers. Mesothelioma had occurred after minimal exposure. Among Londoners aged 60 to 79, the proportion of autopsy lung samples showing asbestos bodies rose from 0 per cent in 1936 to 20 per cent in 1966. Among British doctors, lung cancer incidence rose from about 8 per 100,000 men per year in non-smokers to 350 in men smoking 35 or more cigarettes a day. Smoking was estimated to account for about 88% of cases in male doctors aged 35 to 84. Data on asbestos insulation workers and uranium miners fitted a multiplicative, rather than additive, effect of smoking combined with the occupational agent. The author concluded that prevention lay primarily in reducing cigarette smoking. He proposed banning general tobacco advertising except at the point of sale, and a tax differential favouring pipes and cigars. For asbestos, he recommended discouraging crocidolite use, licensing its import, labelling domestic products, sealing exposed asbestos and disposing of waste safely.

  PubMed has no abstract for this study, and the article doesn't print one. We wrote this summary from the full article with the help of AI. It is not the authors' wording.

Browse every journal in the library or the library by type of article, or return to medical research.